{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:50:00Z","timestamp":1792025400175,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"FEDER-UCLM","award":["UCLM 2022"],"award-info":[{"award-number":["UCLM 2022"]}]},{"name":"FEDER-UCLM","award":["UCLM 2022"],"award-info":[{"award-number":["UCLM 2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02112-6","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:00:48Z","timestamp":1760720448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Short-chain fatty acids in the treatment of ulcerative colitis. Systematic review and meta-analysis"],"prefix":"10.1007","volume":"74","author":[{"given":"V\u00edctor","family":"Serrano-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Carmona-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"L\u00f3pez-Fern\u00e1ndez-Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde Isabel","family":"Castillo-Hermoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rodr\u00edguez-Ca\u00f1amero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"Molina-Madue\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alberto","family":"Laredo-Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"2112_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403:1177\u201391.","journal-title":"Lancet"},{"key":"2112_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562848211006672","volume":"14","author":"R Wilkens","year":"2021","unstructured":"Wilkens R, Novak KL, Maaser C, et al. Relevance of monitoring transmural disease activity in patients with Crohn\u2019s disease: current status and future perspectives. Therap Adv Gastroenterol. 2021;14:1\u201318. https:\/\/doi.org\/10.1177\/17562848211006672.","journal-title":"Therap Adv Gastroenterol"},{"key":"2112_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.rmclc.2019.06.002","volume":"30","author":"M Gompertz","year":"2019","unstructured":"Gompertz M, Sedano R. Clinical and endoscopic manifestations in inflammatory bowel disease. Rev Med Clin Las Condes. 2019;30:273\u201382. https:\/\/doi.org\/10.1016\/j.rmclc.2019.06.002.","journal-title":"Rev Med Clin Las Condes"},{"key":"2112_CR4","first-page":"406","volume":"105","author":"SM Adams","year":"2022","unstructured":"Adams SM, Close ED, Shreenath AP. Ulcerative colitis: rapid evidence review. Am Fam Physician. 2022;105:406\u201311.","journal-title":"Am Fam Physician"},{"issue":"10","key":"2112_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/ueg2.12350","volume":"10","author":"S Aniwan","year":"2022","unstructured":"Aniwan S, Santiago P, Loftus EV, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J. 2022;10(10):1063\u201376.","journal-title":"United Eur Gastroenterol J"},{"key":"2112_CR6","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.3390\/nu16152463","volume":"16","author":"V Serrano-Fernandez","year":"2024","unstructured":"Serrano-Fernandez V, Laredo-Aguilera JA, Navarrete-Tejero C, et al. The role of environmental and nutritional factors in the development of inflammatory bowel diseases: a case-control study. Nutrients. 2024;16:2463. https:\/\/doi.org\/10.3390\/nu16152463.","journal-title":"Nutrients"},{"key":"2112_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","volume":"387","author":"I Cleynen","year":"2016","unstructured":"Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387:156\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(15)00465-1.","journal-title":"Lancet"},{"key":"2112_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021526","volume":"24","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, et al. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023;24:1526. https:\/\/doi.org\/10.3390\/ijms24021526.","journal-title":"Int J Mol Sci"},{"key":"2112_CR9","doi-asserted-by":"publisher","first-page":"II3","DOI":"10.1093\/ecco-jcc\/jjac034","volume":"16","author":"GW Sewell","year":"2022","unstructured":"Sewell GW, Kaser A. Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention. J Crohns Colitis. 2022;16:II3\u201319. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac034.","journal-title":"J Crohns Colitis"},{"key":"2112_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161:1118\u201332.","journal-title":"Gastroenterology"},{"key":"2112_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pop.2023.03.009","volume":"50","author":"LP Bruner","year":"2023","unstructured":"Bruner LP, White AM, Proksell S. Inflammatory bowel disease. Primary Care: Clin Office Pract. 2023;50:411\u201327. https:\/\/doi.org\/10.1016\/j.pop.2023.03.009.","journal-title":"Primary Care: Clin Office Pract"},{"key":"2112_CR12","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3748\/wjg.v30.i15.2068","volume":"30","author":"JK Triantafillidis","year":"2024","unstructured":"Triantafillidis JK, Zografos CG, Konstadoulakis MM, Papalois AE. Combination treatment of inflammatory bowel disease: present status and future perspectives. World J Gastroenterol. 2024;30:2068\u201380.","journal-title":"World J Gastroenterol"},{"key":"2112_CR13","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1053\/j.gastro.2020.01.001","volume":"158","author":"PA Olivera","year":"2020","unstructured":"Olivera PA, Lasa JS, Bonovas S, et al. Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune-mediated diseases: a systematic review and meta-analysis. Gastroenterology. 2020;158:1554\u201373. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.001.","journal-title":"Gastroenterology"},{"key":"2112_CR14","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.3390\/nu15143114","volume":"15","author":"V Serrano Fernandez","year":"2023","unstructured":"Serrano Fernandez V, Seldas Palomino M, Laredo-Aguilera JA, et al. High-fiber diet and Crohn\u2019s disease: systematic review and meta-analysis. Nutrients. 2023;15:3114. https:\/\/doi.org\/10.3390\/nu15143114.","journal-title":"Nutrients"},{"key":"2112_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/nu15010162","volume":"15","author":"K Ferenc","year":"2022","unstructured":"Ferenc K, Jarmakiewicz-Czaja S, Filip R. Components of the fiber diet in the prevention and treatment of IBD\u2014an update. Nutrients. 2022;15:162. https:\/\/doi.org\/10.3390\/nu15010162.","journal-title":"Nutrients"},{"key":"2112_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031105","volume":"23","author":"P Portincasa","year":"2022","unstructured":"Portincasa P, Bonfrate L, Vacca M, et al. Gut microbiota and short chain fatty acids: implications in glucose homeostasis. Int J Mol Sci. 2022;23:1105. https:\/\/doi.org\/10.3390\/ijms23031105.","journal-title":"Int J Mol Sci"},{"key":"2112_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8050788","volume":"8","author":"H Kim","year":"2020","unstructured":"Kim H, Jeong Y, Kang S, et al. Co-culture with Bifidobacterium catenulatum improves the growth, gut colonization, and butyrate production of Faecalibacterium prausnitzii. In vitro and in vivo studies. Microorganisms. 2020;8:788. https:\/\/doi.org\/10.3390\/microorganisms8050788.","journal-title":"Microorganisms"},{"key":"2112_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:1\u201316. https:\/\/doi.org\/10.3389\/fimmu.2019.00277.","journal-title":"Front Immunol"},{"key":"2112_CR19","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms25137379","volume":"25","author":"Y Du","year":"2024","unstructured":"Du Y, He C, An Y, et al. The role of short chain fatty acids in inflammation and body health. Int J Mol Sci. 2024;25:7379. https:\/\/doi.org\/10.3390\/ijms25137379.","journal-title":"Int J Mol Sci"},{"key":"2112_CR20","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1080\/10408398.2021.1895064","volume":"62","author":"A Rauf","year":"2022","unstructured":"Rauf A, Khalil AA, Rahman U, et al. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): an updated review. Crit Rev Food Sci Nutr. 2022;62:6034\u201354.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2112_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52:1\u20138. https:\/\/doi.org\/10.1007\/s00535-016-1242-9.","journal-title":"J Gastroenterol"},{"key":"2112_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12944-024-02203-z","volume":"23","author":"D Firoozi","year":"2024","unstructured":"Firoozi D, Masoumi SJ, Mohammad-Kazem Hosseini Asl S, et al. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial. Lipids Health Dis. 2024;23:216. https:\/\/doi.org\/10.1186\/s12944-024-02203-z.","journal-title":"Lipids Health Dis"},{"key":"2112_CR23","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.3390\/nu14163283","volume":"14","author":"A Pietrzak","year":"2022","unstructured":"Pietrzak A, Banasiuk M, Szczepanik M, et al. Sodium butyrate effectiveness in children and adolescents with newly diagnosed inflammatory bowel diseases\u2014randomized placebo-controlled multicenter trial. Nutrients. 2022;14:3283. https:\/\/doi.org\/10.3390\/nu14163283.","journal-title":"Nutrients"},{"key":"2112_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/nmo.13914","volume":"32","author":"S Facchin","year":"2020","unstructured":"Facchin S, Vitulo N, Calgaro M, et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterol Motil. 2020;32:13\u201325. https:\/\/doi.org\/10.1111\/nmo.13914.","journal-title":"Neurogastroenterol Motil"},{"key":"2112_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-2036.1996.d01-509.x","volume":"10","author":"AH Steinhart","year":"1996","unstructured":"Steinhart AH, Hiruki T, Brzezinski A, Baker JP. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther. 1996;10:729\u201336. https:\/\/doi.org\/10.1046\/j.1365-2036.1996.d01-509.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2112_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2036.1995.tb00386.x","volume":"9","author":"P Vernia","year":"1995","unstructured":"Vernia P, Marcheggiano A, Caprilli R, et al. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther. 1995;9:309\u201313. https:\/\/doi.org\/10.1111\/j.1365-2036.1995.tb00386.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2112_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/cells10071775","volume":"10","author":"PS Salvi","year":"2021","unstructured":"Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10:1775. https:\/\/doi.org\/10.3390\/cells10071775.","journal-title":"Cells"},{"key":"2112_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/life14050559","volume":"14","author":"S Facchin","year":"2024","unstructured":"Facchin S, Bertin L, Bonazzi E, et al. Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications. Life. 2024;14:559. https:\/\/doi.org\/10.3390\/life14050559.","journal-title":"Life"},{"key":"2112_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00203-024-03834-7","volume":"206","author":"MdR Karim","year":"2024","unstructured":"Karim MdR, Iqbal S, Mohammad S, et al. Butyrate\u2019s (a short-chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancer. Arch Microbiol. 2024;206:137. https:\/\/doi.org\/10.1007\/s00203-024-03834-7.","journal-title":"Arch Microbiol"},{"key":"2112_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clnu.2022.10.024","volume":"42","author":"K Hodgkinson","year":"2023","unstructured":"Hodgkinson K, El Abbar F, Dobranowski P, et al. Butyrate\u2019s role in human health and the current progress towards its clinical application to treat gastrointestinal disease. Clin Nutr. 2023;42:61\u201375.","journal-title":"Clin Nutr"},{"key":"2112_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000512952","volume":"28","author":"M Jamka","year":"2021","unstructured":"Jamka M, Kokot M, Kaczmarek N, et al. The effect of sodium butyrate enemas compared with placebo on disease activity, endoscopic scores, and histological and inflammatory parameters in inflammatory bowel diseases: a systematic review of randomised controlled trials. Complement Med Res. 2021;28:344\u201356.","journal-title":"Complement Med Res"},{"key":"2112_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:1\u20139. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"2112_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1\u20138. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"2112_CR34","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/BF02071409","volume":"41","author":"W Scheppach","year":"1996","unstructured":"Scheppach W. Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial. Dig Dis Sci. 1996;41:2254\u20139. https:\/\/doi.org\/10.1007\/BF02071409.","journal-title":"Dig Dis Sci"},{"key":"2112_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.40.4.485","volume":"40","author":"RI Breuer","year":"1997","unstructured":"Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut. 1997;40:485\u201391. https:\/\/doi.org\/10.1136\/gut.40.4.485.","journal-title":"Gut"},{"key":"2112_CR36","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1023\/a:1005537411244","volume":"45","author":"P Vernia","year":"2000","unstructured":"Vernia P, Monteleone G, Grandinetti G, et al. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Dig Dis Sci. 2000;45:976\u201381. https:\/\/doi.org\/10.1023\/a:1005537411244.","journal-title":"Dig Dis Sci"},{"key":"2112_CR37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/003655202317316105","volume":"37","author":"H L\u00fchrs","year":"2002","unstructured":"L\u00fchrs H, Gerke T, M\u00fcller JG, et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol. 2002;37:458\u201366. https:\/\/doi.org\/10.1080\/003655202317316105.","journal-title":"Scand J Gastroenterol"},{"key":"2112_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-2362.2003.01130.x","volume":"33","author":"P Vernia","year":"2003","unstructured":"Vernia P, Annese V, Bresci G, et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest. 2003;33:244\u20138. https:\/\/doi.org\/10.1046\/j.1365-2362.2003.01130.x.","journal-title":"Eur J Clin Invest"},{"key":"2112_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0016-5085(92)91094-k","volume":"103","author":"W Scheppach","year":"1992","unstructured":"Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992;103:51\u20136. https:\/\/doi.org\/10.1016\/0016-5085(92)91094-k.","journal-title":"Gastroenterology"},{"key":"2112_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00042737-199702000-00010","volume":"9","author":"W Scheppach","year":"1997","unstructured":"Scheppach W, M\u00fcller J, Boxberger F, et al. Histological changes in the colonic mucosa following irrigation with short-chain fatty acids. Eur J Gastroenterol Hepatol. 1997;9:163\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2112_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM198901053200105","volume":"320","author":"J Harig","year":"1989","unstructured":"Harig J, Soergel K, Komorowski R, Wood C. Treatment of diversion colitis with short-chain fatty acid irrigation. N Engl J Med. 1989;320:8\u201323.","journal-title":"N Engl J Med"},{"key":"2112_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","volume":"22","author":"MAR Vinolo","year":"2011","unstructured":"Vinolo MAR, Rodrigues HG, Hatanaka E, et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22:849\u201355. https:\/\/doi.org\/10.1016\/j.jnutbio.2010.07.009.","journal-title":"J Nutr Biochem"},{"key":"2112_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/molehr\/gaaa025","volume":"26","author":"HEC Moylan","year":"2020","unstructured":"Moylan HEC, Nguyen-Ngo C, Lim R, Lappas M. The short-chain fatty acids butyrate and propionate protect against inflammation-induced activation of mediators involved in active labor: implications for preterm birth. Mol Hum Reprod. 2020;26:452\u201368. https:\/\/doi.org\/10.1093\/molehr\/gaaa025.","journal-title":"Mol Hum Reprod"},{"key":"2112_CR44","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/molecules28020494","volume":"28","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xi Y, Yang C, et al. Short-chain fatty acids attenuate 5-fluorouracil-induced THP-1 cell inflammation through inhibiting NF-\u03baB\/NLRP3 signaling via glycerolphospholipid and sphingolipid metabolism. Molecules. 2023;28:494. https:\/\/doi.org\/10.3390\/molecules28020494.","journal-title":"Molecules"},{"key":"2112_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895636","author":"B Wang","year":"2022","unstructured":"Wang B, Shen J. NF-\u03baB inducing kinase regulates intestinal immunity and homeostasis. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.895636.","journal-title":"Front Immunol"},{"key":"2112_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1380713","author":"TR Dmytriv","year":"2024","unstructured":"Dmytriv TR, Storey KB, Lushchak VI. Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise. Front Physiol. 2024. https:\/\/doi.org\/10.3389\/fphys.2024.1380713.","journal-title":"Front Physiol"},{"key":"2112_CR47","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"D Yao","year":"2019","unstructured":"Yao D, Dong M, Dai C, Wu S. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis. 2019;25:1595\u2013602. https:\/\/doi.org\/10.1093\/ibd\/izz149.","journal-title":"Inflamm Bowel Dis"},{"key":"2112_CR48","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3390\/ijms22063061","volume":"22","author":"N Gasaly","year":"2021","unstructured":"Gasaly N, Hermoso MA, Gotteland M. Butyrate and the fine-tuning of colonic homeostasis: implication for inflammatory bowel diseases. Int J Mol Sci. 2021;22:3061. https:\/\/doi.org\/10.3390\/ijms22063061.","journal-title":"Int J Mol Sci"},{"key":"2112_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s13668-023-00461-4","volume":"12","author":"O Mohamed Elfadil","year":"2023","unstructured":"Mohamed Elfadil O, Mundi MS, Abdelmagid MG, et al. Butyrate: more than a short chain fatty acid. Curr Nutr Rep. 2023;12:255\u201362.","journal-title":"Curr Nutr Rep"},{"key":"2112_CR50","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3390\/nu15102275","volume":"15","author":"N Recharla","year":"2023","unstructured":"Recharla N, Geesala R, Shi X-Z. Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review. Nutrients. 2023;15:2275. https:\/\/doi.org\/10.3390\/nu15102275.","journal-title":"Nutrients"},{"key":"2112_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1203\/01.pdr.0000250014.92242.f3","volume":"61","author":"L Peng","year":"2007","unstructured":"Peng L, He Z, Chen W, et al. Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007;61:37\u201341. https:\/\/doi.org\/10.1203\/01.pdr.0000250014.92242.f3.","journal-title":"Pediatr Res"},{"key":"2112_CR52","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","volume":"13","author":"S Tedelind","year":"2007","unstructured":"Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol. 2007;13:2826. https:\/\/doi.org\/10.3748\/wjg.v13.i20.2826.","journal-title":"World J Gastroenterol"},{"key":"2112_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dld.2015.09.005","volume":"48","author":"C Luceri","year":"2016","unstructured":"Luceri C, Femia AP, Fazi M, et al. Effect of butyrate enemas on gene expression profiles and endoscopic\/histopathological scores of diverted colorectal mucosa: a randomized trial. Dig Liver Dis. 2016;48:27\u201333. https:\/\/doi.org\/10.1016\/j.dld.2015.09.005.","journal-title":"Dig Liver Dis"},{"key":"2112_CR54","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/ibd\/izz188","volume":"25","author":"X Zhuang","year":"2019","unstructured":"Zhuang X, Li T, Li M, et al. Systematic review and meta-analysis: short-chain fatty acid characterization in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1751\u201363.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02112-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:42Z","timestamp":1767200022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02112-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2112"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02112-6","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript does not require ethical approval from an ethics committee, as it is a systematic review of existing literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This review was registered in International Prospective Register of Systematic Reviews with registration number CRD42024565157.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Review registration"}}],"article-number":"142"}}